Cargando…
Antibiotic Therapy in the Treatment of COVID-19 Pneumonia: Who and When?
Background: COVID-19 imposes challenges in antibiotic decision-making due to similarities between bacterial pneumonia and moderate to severe COVID-19. We evaluated the effects of antibiotic therapy on the clinical outcomes of COVID-19 pneumonia patients and diagnostic accuracy of key inflammatory ma...
Autores principales: | Ng, Tat Ming, Ong, Sean W. X., Loo, Audrey Y. X., Tan, Sock Hoon, Tay, Hui Lin, Yap, Min Yi, Lye, David C., Lee, Tau Hong, Young, Barnaby E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868256/ https://www.ncbi.nlm.nih.gov/pubmed/35203787 http://dx.doi.org/10.3390/antibiotics11020184 |
Ejemplares similares
-
A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19)
por: Tan, Sock Hoon, et al.
Publicado: (2021) -
186. Effective Antimicrobial StewaRdship StrategIES (ARIES): Cluster-Randomized Trial of a Clinical Decision Support System to Supplement Antibiotic Prospective Review and Feedback
por: Heng, Shi Thong, et al.
Publicado: (2018) -
Sustaining Antimicrobial Stewardship in a High–Antibiotic Resistance Setting
por: Ng, Tat Ming, et al.
Publicado: (2022) -
Gut Microbiota Modulation: Implications for Infection Control and Antimicrobial Stewardship
por: Tan, Glorijoy Shi En, et al.
Publicado: (2020) -
Effective Antimicrobial StewaRdship StrategIES (ARIES): Cluster Randomized Trial of Computerized Decision Support System and Prospective Review and Feedback
por: Heng, Shi Thong, et al.
Publicado: (2020)